Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
OranjeBTC Buys Back 1,000,700 Shares for R$ 6.9 Million

OranjeBTC Buys Back 1,000,700 Shares for R$ 6.9 Million

BitgetBitget2026/11/09 01:01
  • OranjeBTC repurchased 1,000,700 common shares for BRL 6.9 million during November 3-8, 2026.
  • The average repurchase price was BRL 6.8981, with the shares’ discount to mNAV narrowing slightly by week-end.
  • Bitcoin per share rose 0.73% during the week to 2,874 satoshis.
  • Week-end Bitcoin reserves totaled 3,950 BTC, with 137,452,180 common shares outstanding, excluding treasury shares.
  • Gross Bitcoin yield reached 2.8% for the fourth quarter of 2026, versus 25.44% year to date.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oranjebtc SA Educacao e Investimento published the original content used to generate this news brief on November 08, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.

NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.

华尔街见闻•2026/11/09 22:12